The test, when used for women without cell changes but who had human papilloma virus, accurately predicted 55 percent would have cell changes in the next four years, according to the report.
The study, published in Genome Medicine, studied 1,254 cervical screening samples from routine pap smear tests. Not only could they better identify women with advanced cell changes who needed treatment, they could also spot ovarian and breast cancer or predict the likelihood of their development.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
